NovoCure Ltd (NVCR): Long-Term Debt
Older than the company's other figures. The latest Long-Term Debt is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$568.82M
As of 2023-12-31
+9.8%
3-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $568.82M | +0.6% | 2024-02-22, Balance as of period end |
| 2022-12-31 | $565.51M | +0.6% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $562.22M | +30.8% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $429.90M | +187.7% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $149.42M | n/a | 2021-02-25, Balance as of period end |